Danimer Scientific, Inc. (NYSE:DNMR) Q3 2023 Earnings Call Transcript November 14, 2023 4:30 PM ET Company Participants James Palczynski - IR Steve Croskrey - Chairman and CEO Mike Hajost - CFO Conference Call Participants Jon Tanwanteng - CGS Securities Thomas Boyes - TD Cowen Charles Neivert - Piper Sandler Kevin Estok - Jefferies Operator Greetings. Welcome to the Danimer Scientific 2023 Third Quarter Earnings Call. At this time all lines are in listen-only mode. Following the presentation, we will condu ...

Forward-Looking Statements and Non-GAAP Financial Results No representations or warranties, express or implied, are given in, or in respect of, this Presentation. To the fullest extent permitted by law in no circumstances will Danimer Scientific, Inc. (the "Company") or any of its subsidiaries, stockholders, affiliates, representatives, directors, officers, employees, advisers, or agents be responsible or liable for a direct, indirect, or consequential loss or loss of profit arising from the use of this Pre ...

o UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission File Number: 001-39280 DANIMER SCIENTIFIC, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 84-1924518 (State or other juri ...

4 (3) Excludes Stock-based compensation, Depreciation & amortization and one-time items | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |-----------------------------------------|-------|-------|-------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | dan scientific A Biotechnology Company | | | | | | | | | | USE OF PROJECTIONS 6 10 Forward-Looking Statements and Non-GAAP Financial Results This Presentation contains projected financial information ...

Danimer Scientific, Inc. (NYSE:DNMR) Q2 2023 Earnings Conference Call August 8, 2023 4:30 PM ET Company Participants James Palczynski - IR Stephen Croskrey - CEO & Chairman Michael Hajost - CFO Conference Call Participants Thomas Boyes - TD Cowen Dan Moore - CJS Securities Operator Greetings. Welcome to the Danimer Scientific 2023 Second Quarter Earnings Call. I would now like to turn the presentation over to Mr. James Palczynski, the company’s Investor Relations representative. James Palczynski Thank you, ...

o UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission File Number: 001-39280 DANIMER SCIENTIFIC, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 84-1924518 ( State or other jurisdic ...

Danimer Scientific, Inc. (NYSE:DNMR) Q1 2023 Earnings Conference Call May 10, 2023 5:00 PM ET Company Participants James Palczynski - IR Stephen Croskrey - CEO & Chairman Michael Hajost - CFO Conference Call Participants Kevin Estok - Jefferies Thomas Boyes - TD Cowen Jonathan Tanwanteng - CJS Securities Charles Neivert - Piper Sandler & Co. Operator Greetings. Welcome to the Danimer Scientific 2023 First Quarter Earnings Call. [Operator Instructions]. This call is being recorded on Wednesday, May 10 2023. ...

o UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission File Number: 001-39280 DANIMER SCIENTIFIC, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 84-1924518 ( State or other jurisdi ...

Danimer Scientific, Inc. (NYSE:DNMR) Q4 2022 Earnings Conference Call March 28, 2023 5:00 PM ET Company Participants James Palczynski - Investor Relations Steve Croskrey - Chairman and Chief Executive Officer Mike Hajost - Chief Financial Officer Conference Call Participants Jon Tanwanteng - CJS Securities Kevin Estok - Jefferies Operator Greetings and welcome to the Danimer Scientific 2022 Fourth Quarter and Full Year Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39280 DANIMER SCIENTIFIC, INC. (Exact name of Registrant as specified in its Charter) Delaware 84-1924518 (State or other jurisdictio ...